Oracle Corporation Oracle®'s Adverse Event Reporting System (AERS) and Qscan offer and end-to-end platform for pharmacovigilence. AERS, a robust solution for product safety monitoring and pharmacovigilance that tracks events from multiple sources, including the internet, patients and physicians, has been integratrated with Qscan to provide a best-of-breed enterprise risk management architecture that leverages advanced analytics to help enhance safety monitoring capabilities and streamline compliance with pharmacovigilance requirements. | > www.oracle.com United Biosource Corporation UBC brings a wide range of epidemiological and meta-analytical expertise, combined with successful regulatory experience. DrugLogic brings the power of Qscan, its flagship product, and systems integration, medical coding and medical dictionary expertise. This collaboration yields a powerful integrated capability to serve clients. > www.unitedbiosource.com The Uppsala Monitoring Center In a unique co-development and co-marketing partnership, the WHO worldwide database of drug safety information, comprised of over three million reports from 67 countries, will now be accessible through Qscanþ World. > www.who-umc.org Patni (formerly Taratec) Patni brings deep domain expertise in the life sciences industry, excellent understanding of the regulated industry, long-term client relationships with the industry's leading companies, and a fantastic reputation for service delivery. Patni jointly markets DrugLogic's Qscan family of products. > www.taratec.com BioPharm Systems The partnership with BioPharm Systems couples the Qscan product line with BioPharms trusted services for drug safety and clinical database applications. This provides an integrated, validated environment for signal management and risk assessment. > www.biopharm.com